Editas Medicine Inc (EDIT)
5.67
+0.05
(+0.89%)
USD |
NASDAQ |
May 03, 16:00
5.67
0.00 (0.00%)
After-Hours: 20:00
Editas Medicine Market Cap: 463.88M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 03, 2024 | 463.88M |
May 02, 2024 | 459.79M |
May 01, 2024 | 447.52M |
April 30, 2024 | 426.25M |
April 29, 2024 | 439.34M |
April 26, 2024 | 435.25M |
April 25, 2024 | 427.07M |
April 24, 2024 | 437.70M |
April 23, 2024 | 446.70M |
April 22, 2024 | 458.16M |
April 19, 2024 | 449.16M |
April 18, 2024 | 454.07M |
April 17, 2024 | 458.98M |
April 16, 2024 | 478.61M |
April 15, 2024 | 497.43M |
April 12, 2024 | 508.06M |
April 11, 2024 | 538.34M |
April 10, 2024 | 542.43M |
April 09, 2024 | 573.52M |
April 08, 2024 | 549.79M |
April 05, 2024 | 549.79M |
April 04, 2024 | 557.15M |
April 03, 2024 | 561.24M |
April 02, 2024 | 562.06M |
April 01, 2024 | 595.61M |
Date | Value |
---|---|
March 28, 2024 | 607.06M |
March 27, 2024 | 608.70M |
March 26, 2024 | 590.70M |
March 25, 2024 | 602.15M |
March 22, 2024 | 611.15M |
March 21, 2024 | 640.60M |
March 20, 2024 | 647.97M |
March 19, 2024 | 634.06M |
March 18, 2024 | 631.60M |
March 15, 2024 | 665.15M |
March 14, 2024 | 666.78M |
March 13, 2024 | 702.78M |
March 12, 2024 | 704.42M |
March 11, 2024 | 736.33M |
March 08, 2024 | 749.42M |
March 07, 2024 | 724.05M |
March 06, 2024 | 742.87M |
March 05, 2024 | 747.78M |
March 04, 2024 | 811.59M |
March 01, 2024 | 861.50M |
February 29, 2024 | 823.05M |
February 28, 2024 | 905.68M |
February 27, 2024 | 724.87M |
February 26, 2024 | 659.42M |
February 23, 2024 | 638.97M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
426.25M
Minimum
Apr 30 2024
5.667B
Maximum
Jan 08 2021
1.525B
Average
1.185B
Median
Jul 05 2019
Market Cap Benchmarks
Vertex Pharmaceuticals Inc | 103.60B |
Bristol-Myers Squibb Co | 89.17B |
Regeneron Pharmaceuticals Inc | 105.45B |
Cabaletta Bio Inc | 597.71M |
Moderna Inc | 47.90B |
Market Cap Related Metrics
PS Ratio | 5.511 |
Price to Book Value | 1.329 |
Price | 5.67 |
Earnings Yield | -36.16% |